Supply report · August 2026 register copy
Antibiotics in Nigeria: the registration data
Across the 15 antibiotic molecules Ogbogwu tracks, our August 2026 copy of the NAFDAC Greenbook lists 908 active registrations held by 315 companies — plus 784 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 908
- Companies
- 315
- New in the last 12 months
- 66
- Renewals due within a year
- 262
Who holds the registrations
The ten companies with the most active antibiotic registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Emzor Pharmaceutical Industries— 16 active
- 2.Shalina Healthcare Nigeria— 16 active
- 3.Fidson Healthcare— 14 active
- 4.Evans Therapeutics— 13 active
- 5.Greenlife Pharmaceutical— 13 active
- 6.Phillips Pharmaceuticals (Nigeria)— 13 active
- 7.First Vadis Pharmaceutical Industries— 12 active
- 8.Synermed— 12 active
- 9.Drugfield Pharmaceuticals— 11 active
- 10.Krishat Pharma Industries— 11 active
Where the products are made
Maker country as the register records it, across the 908 active registrations.
- India— 531 (58%)
- Nigeria— 219 (24%)
- China— 121 (13%)
- Bangladesh— 5 (1%)
- Pakistan— 5 (1%)
- UK— 5 (1%)
- Austria— 3 (0%)
- Malaysia— 3 (0%)
Dosage forms
- Tablet— 386 active
- Powder for injection— 113 active
- Injection— 84 active
- Suspension— 71 active
- Capsule— 60 active
- Powder for suspension— 54 active
- Cream— 33 active
- Caplet— 18 active
Newest registrations
The latest antibiotic approvals in our copy — 66 products were registered in the twelve months to August 2026.
262 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Amoxicillin-Clavulanate — 110 active registrations
- Ceftriaxone — 105 active registrations
- Ciprofloxacin — 92 active registrations
- Cefuroxime — 88 active registrations
- Azithromycin — 73 active registrations
- Metronidazole — 65 active registrations
- Cefixime — 46 active registrations
- Amoxicillin — 43 active registrations
- Levofloxacin — 39 active registrations
- Co-trimoxazole (Sulfamethoxazole/Trimethoprim) — 34 active registrations
- Ampicillin + Cloxacillin — 29 active registrations
- Gentamicin — 29 active registrations
- Erythromycin — 25 active registrations
- Cefpodoxime — 18 active registrations
- Doxycycline — 13 active registrations
“Antibiotics” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Ciprofloxacin 500 mg tablet — 54 companies
- Ceftriaxone 1 g powder for injection — 43 companies
- Azithromycin 500 mg tablet — 42 companies
- Cefuroxime 500 mg tablet — 36 companies
- Amoxicillin 500 mg + Clavulanic Acid 125 mg tablet — 33 companies
- Ceftriaxone 1 g injection — 31 companies
Manufacturing or exporting antibiotic medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.